PEP/NEWS — Peptide intel. Daily.

Use Code THOMAS20 for 20% off Your First Order of SEED: http://seed.com/thomasyt This video does contain a paid partnership with a brand that helps to support this channel. It is because of brands like this that we are able to provide the

The Ask DLG Show Episode #391 is streaming LIVE at 8:30 AM EST! Need answers to your health questions? Join The Ask DLG Show at 8:30AM ET. ✨ Find Your Personalized Health Routine From energy and digestion to weight management and joint co

Pre-order The Hard Truth + get $494 in FREE bonuses (course, early chapters & live masterclass). https://www.renamalikmd.com/hardtruth In this episode, Dr. Rena Malik explores key issues in urologic cancer detection and management with Dr.

Jake Becraft is the CEO and co-founder of Strand Therapeutics, a company building one of the most advanced programmable genetic medicine platforms in biotechnology. Under his leadership, Strand is redefining what RNA medicines can do by ena

Bryan Johnson breaks down the nine evening systems behind his self-reported 99.4th-percentile sleep performance. The write-up emphasizes circadian timing and metabolic state — relevant to anyone researching DSIP (a peptide studied for sleep architecture) or sleep-phase optimization.

Johnson outlines three zero-cost health metrics — including resting heart rate before sleep as a metabolic and fitness signal. Useful baseline framework for researchers tracking biological age markers alongside peptide intervention timelines.

Researchers have shown how early cancer cells actively reshape neighboring tissue to create a growth-friendly niche. The finding is directly relevant to ongoing work on peptides and oncology — including the Research Vials series on how tumors hijack signaling pathways.

Researchers have mapped how omega-3 fatty acids reduce cellular senescence in the kidneys, helping explain their benefit in chronic kidney disease. The senolytic angle here is relevant — senescent cell clearance is a core mechanism also being explored with FOXO4-DRI and related peptides.

A recent study found perimenopausal women had roughly twice the odds of poor cardiovascular health compared to premenopausal peers. The transition window is emerging as a critical intervention target — relevant to kisspeptin research and hormonal optimization strategies.

Altos Labs researchers have published a machine learning model that predicts how cells' gene expression shifts in response to interventions — end to end. This kind of predictive platform could eventually streamline how peptide candidates are screened before costly animal or human trials.

Sami Inkinen of Virta Health joins Tim Ferriss to discuss reversing type 2 diabetes at scale using nutrition and technology — without drugs. The metabolic framework discussed parallels GLP-1 receptor agonist research and the broader conversation around insulin sensitivity and HOMA-IR (a marker of insulin resistance).

Part two of Research Vials' cancer series maps how tumors spread and which checkpoint pathways they exploit. The piece then pivots to early peptide-specific data — a useful reference for researchers navigating the oncology-adjacent peptide literature.